---
title: "LifeSci Capital Sticks to Their Buy Rating for Satellos Bioscience (MSLE)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297428498.md"
description: "LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Satellos Bioscience yesterday and set a price target of $22.00. According to TipRanks, Brisebois is a 4-star analyst with an average return of 5.2% and a 43.36% success rate. Brisebois covers the Healthcare sector, focusing on stocks such as Definium Therapeutics, Opus Genetics, and Praxis Precision Medicines. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Satellos Bioscience with a $25.75 average price target."
datetime: "2026-08-30T13:25:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297428498.md)
  - [en](https://longbridge.com/en/news/297428498.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297428498.md)
generator: "portal-rs"
---

# LifeSci Capital Sticks to Their Buy Rating for Satellos Bioscience (MSLE)

LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Satellos Bioscience yesterday and set a price target of $22.00.

According to TipRanks, Brisebois is a 4-star analyst with an average return of 5.2% and a 43.36% success rate. Brisebois covers the Healthcare sector, focusing on stocks such as Definium Therapeutics, Opus Genetics, and Praxis Precision Medicines.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Satellos Bioscience with a $25.75 average price target.

### Related Stocks

- [MSLE.US](https://longbridge.com/en/quote/MSLE.US.md)
- [DFTX.US](https://longbridge.com/en/quote/DFTX.US.md)
- [IRD.US](https://longbridge.com/en/quote/IRD.US.md)
- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)

## Related News & Research

- [Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress](https://longbridge.com/en/news/299042549.md)
- [Stonepine Capital Management LLC Increases Stock Position in Satellos Bioscience Inc. $MSLE](https://longbridge.com/en/news/297306052.md)
- [Satellos Bioscience releases investor presentation on Duchenne muscular dystrophy program](https://longbridge.com/en/news/298645579.md)
- [Why Did SanDisk Stock Surge 6%? Rosenblatt Initiates With Buy as AI Storage Demand Keeps Heating Up](https://longbridge.com/en/news/299852158.md)
- [IM Cannabis Stock Falls after $1.31 Million Offering Follows Drone Deal](https://longbridge.com/en/news/299915374.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**